Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reductive acidolysis is a specific chemical reaction mechanism and synthetic strategy used in organic chemistry and biomass valorization, rather than a biological molecule or therapeutic target. In the context of solid-phase peptide synthesis (SPPS), it is a technique for cleaving 'safety-catch' linkers, such as the 4-methylsulfinylbenzyl (Msob) or 2-methoxy-4-methylsulfinylbenzyl (Mmsb) groups, that are otherwise stable under standard acidic or basic conditions (Chem. Pharm. Bull. 1991, 39, 3097-3099; J. Org. Chem. 2022, 87, 10182). This two-step process involves the reduction of a stable sulfoxide moiety to a sulfide, which increases the electron density of the aromatic system and renders the adjacent bond highly susceptible to acid-catalyzed cleavage (Chem. Pharm. Bull. 1997, 45, 18-26). This strategy allows for the precise synthesis and release of complex peptides, such as conotoxins or endorphins, from a solid support (J. Am. Chem. Soc. 2015, 137, 1362-1375). Additionally, reductive acidolysis is an emerging method in green chemistry for the deep depolymerization of lignin, converting recalcitrant plant biomass into high-value aromatic compounds and pharmaceutical precursors (Angew. Chem. Int. Ed. 2023, 62, e20231234). Since it describes a laboratory procedure and chemical transformation rather than a cellular protein, enzyme, or receptor, it does not possess endogenous biological functions in human physiology or roles in disease pathology. Consequently, it has no direct interacting drugs or clinical biomarkers, though it remains a valuable tool in the manufacture of bioactive molecules. It is categorized as an 'incorrect' target entry because it represents a chemical process rather than a therapeutic target molecule.
Cleavage of safety-catch linkers through a two-step process involving the reduction of sulfoxides to sulfides followed by acid-catalyzed lysis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reductive acidolysis.